Mitochondrial Diseases: Hope for the Future.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32220313.
- Also identified by DOI 10.1016/j.cell.2020.02.051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.
Medical subject headings
- Mitochondria
- Mitochondrial Diseases